| 1 |
Partly verified |
Full text not readStored summary read |
N01 · Evidence conditionWhich original long-term subclaim is being checked?Required |
The selected claim is long-term whey-only HbA1c or complication benefit. The parent and other short-term subclaim concern acute or several-day postprandial glucose. Leave separate direct evidence needs for long-term whey-only HbA1c and complications. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Original long-term claim and its boundary with parent/short-term context |
Material needed: Direct long-term whey-only endpoint and analysis material is unverified. This records needed materials; no new research was executed. |
| 2 |
Partly verified |
Full text not readStored summary read |
N02 · Evidence conditionAre subclaim ? and parent C50 separate?Required |
The selected long-term subclaim is graded ?, with an original note that longer trials used combinations and cannot isolate whey. Score/status are absent. Parent C50 is historical short-term postprandial-glucose context. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Original ? and note, absent score/status, and parent C50/safety |
Material needed: Subclaim score/status fields are absent. This records needed materials; no new research was executed. |
| 3 |
Partly verified |
Full text not readStored summary read |
N03 · Evidence conditionWho is the long-term whey-only question about?Required |
The research description concerns non-insulin-treated adults; individual evidence entries say adults with type 2 diabetes or 18 participants. Long-term whey-only eligibility, age, baseline HbA1c, medication and complication-risk populations are unverified. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Adults with type 2 diabetes, original non-insulin-treated context and long-term eligibility |
Material needed: Long-term whey-only populations, baseline/complication status, treatment and exclusions are unverified. This records needed materials; no new research was executed. |
| 4 |
Partly verified |
Full text not readStored summary read |
N04 · Evidence conditionAre long-term whey alone and combinations different interventions?Required |
The original key explanation, research description and product information distinguish whey plus guar and MCT plus WPI from whey alone. Selected long-term whey-only formulation, components, dose and actual exposure are unverified. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Whey formulation/ingredient, WPI, guar/MCT and long-term whey-only specifications |
Material needed: Long-term whey-only formulation, components, dose, isolated comparison and actual adherence are unverified. This records needed materials; no new research was executed. |
| 5 |
Unverified |
Full text not readStored summary read |
N05 · Evidence conditionWhat are the actual long-term duration and observation windows?Required |
The selected subclaim/parent describe uncertain long-term whey-only effects. Exact long-term duration, HbA1c assessment dates and complication windows are absent from the stored summary. The acute 180-minute summary and Smith's 7 days are short-term background. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Long-term exposure/follow-up, HbA1c times, complication windows and post-intervention follow-up |
Material needed: Long-term whey-only exposure/follow-up, assessment times and event windows are unverified. This records needed materials; no new research was executed. |
| 6 |
Unverified |
Full text not readStored summary read |
N06 · Evidence conditionHow is long-term HbA1c defined?Required |
The selected subclaim includes an HbA1c question, but the three reports' endpoints are acute glucose/hormones, postprandial iAUC/time above range and 24-hour/daytime iAUC. Long-term whey-only HbA1c definitions, measurement, units and times are unverified. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
HbA1c units, baseline/end/change, times, measurement and model |
Material needed: Whey-only HbA1c definitions/units, baseline/change, times and models are unverified. This records needed materials; no new research was executed. |
| 7 |
Unverified |
Full text not readStored summary read |
N07 · Evidence conditionIs a between-group long-term whey-only HbA1c effect preserved?Required |
The original subclaim note says longer combination trials prevent isolating whey. Stored material lacks a long-term whey-only between-group HbA1c effect, CI or adjusted estimate. This is unverified within the present preservation/reading scope. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Long-term whey-only arm values, between-group effect, adjustment/CI and control |
Material needed: Long-term whey-only arm values, effects/CIs, adjustment and comparator are unverified. This records needed materials; no new research was executed. |
| 8 |
Unverified |
Full text not readStored summary read |
N08 · Evidence conditionWhat are long-term HbA1c populations, denominators and missing data?Required |
Original sample sizes exist for acute 15-person and 7-day 18-person studies. Zameer's sample wording only says adults with type 2 diabetes. Long-term whey-only HbA1c arm-specific allocation/completion/analysis counts and attrition/missing-data handling are unverified. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Allocation/completion/analysis, arm-specific sample sizes, medication, missing data and ITT/PP |
Material needed: Long-term whey-only arm-specific analysis/denominators, missing data/attrition and target effects are unverified. This records needed materials; no new research was executed. |
| 9 |
Unverified |
Full text not readStored summary read |
N09 · Evidence conditionWhich complications and follow-up windows are being asked about?Required |
The selected subclaim includes complication benefit, but specific event definitions, occurrence/progression, collection/adjudication and follow-up windows are absent. The original counterpoint/synthesis distinguishes insulin/GLP-1 from clinical complication outcomes. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Complication definitions, collection/adjudication, occurrence/progression and follow-up |
Material needed: Direct complication definitions, collection/adjudication, occurrence/progression and follow-up are unverified. This records needed materials; no new research was executed. |
| 10 |
Unverified |
Full text not readStored summary read |
N10 · Evidence conditionAre direct complication effects, denominators and CIs available?Required |
The original summary does not preserve long-term whey-only complication event counts, denominators or effects/CIs. Original advertising-boundary and summary wording describe the problem of extending short-term signals into treatment or long-term benefit. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Whey-only arm-specific events/denominators, effects/CIs, losses and comparator/medication |
Material needed: Direct complication events/denominators, effects/CIs, follow-up losses and comparator are unverified. This records needed materials; no new research was executed. |
| 11 |
Partly verified |
Full text not readStored summary read |
N11 · Evidence conditionAt what level is whey-plus-guar material identified?Required |
The original key explanation, research description and product information mention whey plus guar, but no separate guar bibliography or evidence entry is present. Exact formulation, duration, sample size, endpoints/effects are unverified; no fictional report is added. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Original combination mention, bibliography/identity, composition, duration, comparator and results |
Material needed: Whey-plus-guar bibliography/registration, composition, duration, population and effects are unverified. This records needed materials; no new research was executed. |
| 12 |
Partly verified |
Full text not readStored summary read |
N12 · Evidence conditionHow does MCT plus WPI differ from whey alone?Required |
Zameer's original design is a randomized MCT-plus-WPI crossover trial. It is not whey alone; component amounts/calories, comparator, actual adherence and exact intervention duration are unverified in the current summary. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Zameer combination components, formulation/dose, comparator/duration and adherence |
Material needed: Component amounts/calories, comparator, exposure/duration and isolated contribution are unverified. This records needed materials; no new research was executed. |
| 13 |
Partly verified |
Full text not readStored summary read |
N13 · Evidence conditionWhat is the scope of null primary 24-hour/daytime iAUC?Required |
Zameer's endpoint is 24-hour/daytime glucose iAUC, with null primary iAUC results. Exact effects/CIs, P values, units and denominators are unverified. This is not a direct whey-only HbA1c/complication result. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Zameer endpoints/results, original hierarchy, exact effects/intervals and denominators |
Material needed: Original iAUC effects/CIs, units/denominators and registered plans/analysis are unverified. This records needed materials; no new research was executed. |
| 14 |
Partly verified |
Full text not readStored summary read |
N14 · Evidence conditionWhat was the acute 50 g/30-minute-premeal exposure?Required |
Original wording records 50 g used 30 minutes before a meal and a 180-minute glucose response. Manufacturing, formulation, control contents and meal/dose adherence are unverified; these are not long-term whey-only exposure specifications. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Jakubowicz acute 50 g, 30 minutes before a meal, 180 minutes and actual formulation/control |
Material needed: Formulation/manufacturing, control/meal and actual exposure are unverified. This records needed materials; no new research was executed. |
| 15 |
Partly verified |
Full text not readStored summary read |
N15 · Evidence conditionWhat are the original 28% glucose and 105% insulin findings?Required |
The key report records glucose 28% lower and insulin 105% higher. The original answer/endpoint describes a GLP-1 increase without an exact increase value. Exact absolute values/CIs, denominators and models are unverified. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Original response percentages, 180 minutes, scale/model, denominators and intervals |
Material needed: Response definitions, absolute values/denominators, CIs and exact GLP-1 values are unverified. This records needed materials; no new research was executed. |
| 16 |
Partly verified |
Full text not readStored summary read |
N16 · Evidence conditionDo insulin and GLP-1 answer the long-term clinical question?Required |
The original counterpoint/synthesis says higher insulin/GLP-1 are mechanistic outcomes and do not guarantee long-term HbA1c, complication or medication-reduction benefit. Direct long-term links and mediation analyses are unverified. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Mechanistic measures versus separate direct HbA1c, complication and medication outcomes |
Material needed: Links between mechanisms and direct long-term outcomes, mediation and clinical analyses are unverified. This records needed materials; no new research was executed. |
| 17 |
Partly verified |
Full text not readStored summary read |
N17 · Evidence conditionWhat is the scope of the 15.6 g protein drink and 7-day study?Required |
The research description records a premeal 15.6 g protein drink and Smith's citation describes a 7-day free-living drink study. Exact whey-product composition, actual intake and identical long-term exposure are unverified. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Smith's 7 days, premeal drink, original 15.6 g, product/control and actual exposure |
Material needed: Product composition, net content, actual adherence and identical long-term exposure are unverified. This records needed materials; no new research was executed. |
| 18 |
Partly verified |
Full text not readStored summary read |
N18 · Evidence conditionWhat does iAUC 1.6±0.6 versus 2.1±0.9 describe?Required |
Smith's result is iAUC 1.6±0.6 versus 2.1±0.9, P=.003. Exact iAUC units/time, the meaning of ±, model, exact denominator and intervals are unverified in the stored summary. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Original iAUC values, P=.003, units/time, meaning of ± and denominator/model |
Material needed: iAUC units/time, the meaning of ±, denominators/models and CIs are unverified. This records needed materials; no new research was executed. |
| 19 |
Partly verified |
Full text not readStored summary read |
N19 · Evidence conditionWhat does approximately 100 kcal versus 34 kcal limit?Required |
The original explanation records approximately 100 kcal for whey drink and approximately 34 kcal for control, with a non-isocaloric comparison. Product/meal composition beyond protein, total-intake changes and isolated whey contribution are unverified. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Smith drink calories, calorie imbalance, control composition, meals and other nutrients |
Material needed: Composition, meal/total-intake changes and between-condition nutrient contributions are unverified. This records needed materials; no new research was executed. |
| 20 |
Partly verified |
Full text not readStored summary read |
N20 · Evidence conditionWhat is known about Smith's registered/published primary mismatch?Required |
Original answer, explanation and citation wording record a difference between the registered primary outcome and the published primary outcome. Smith's evidence registration field is ISRCTN17563146. Exact endpoint names/times, amendments and chronology are unverified; registration was not newly read. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Original hierarchy mismatch, ISRCTN and registered/protocol/published endpoints |
Material needed: Registered/published primary names, analysis/times and registration chronology/amendments are unverified. This records needed materials; no new research was executed. |
| 21 |
Unverified |
Full text not readStored summary read |
N21 · Evidence conditionHow are long-term whey-only controls and shared treatment established?Required |
The preserved population/exposure summary says control drink. Long-term whey-only control calories/composition, meal/lifestyle management, maintained/changed medication, contact and adherence are unverified. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Long-term whey-only controls, calories/contact, meals/lifestyle/medication and rescue treatment |
Material needed: Long-term whey-only controls/shared care, meal/medication changes and contact are unverified. This records needed materials; no new research was executed. |
| 22 |
Partly verified |
Full text not readStored summary read |
N22 · Evidence conditionWhat stages do 15, 18 and nonnumeric sample wording represent?Required |
Original sample wording is 15 adults with type 2 diabetes for Jakubowicz, 18 participants for Smith, and adults with type 2 diabetes for Zameer. Arm-specific allocation/completion/analysis, crossover/endpoint denominators and attrition are unverified. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Original samples, allocation/completion/analysis, crossover/endpoint-specific counts and missing data |
Material needed: Allocation/completion, endpoint/crossover denominators and missing data/attrition are unverified. This records needed materials; no new research was executed. |
| 23 |
Partly verified |
Full text not readStored summary read |
N23 · Evidence conditionWhat are crossover sequence, carryover, period effects and analysis?Required |
Jakubowicz is an acute randomized crossover trial, Smith a 7-day free-living crossover trial and Zameer a randomized MCT-plus-WPI crossover trial. Actual sequence/concealment, washout, carryover/period effects and within-person analyses are unverified. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Acute/7-day/MCT crossover, sequence/washout and within-person repeated analysis |
Material needed: Allocation/concealment, sequence/washout, carryover/period effects and repeated analysis are unverified. This records needed materials; no new research was executed. |
| 24 |
Partly verified |
Full text not readStored summary read |
N24 · Evidence conditionHow do glucose, hormone and long-term outcome measurements differ?Required |
Original measures are 180-minute glucose/hormones, postprandial iAUC/time above range and 24-hour/daytime iAUC. Devices, measurement/calculation, assessor/analyst knowledge and long-term HbA1c/complication collection methods are unverified. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Outcome-specific devices, units/times, blinding, collection/adjudication and repeats |
Material needed: Measurement/calculation, blinding and long-term measurement/adjudication are unverified. This records needed materials; no new research was executed. |
| 25 |
Partly verified |
Full text not readStored summary read |
N25 · Evidence conditionHow do shared medication/meals connect with long-term analysis?Required |
Original context concerns non-insulin-treated adults and premeal drinks. Actual medication types/doses, meals/total intake, arm-specific changes and their treatment in long-term HbA1c/event analysis are unverified. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Medication, meals/total intake, changes, adherence and comparator/analysis |
Material needed: Medication/meals, changes/adherence and long-term analysis are unverified. This records needed materials; no new research was executed. |
| 26 |
Unverified |
Full text not readStored summary read |
N26 · Evidence conditionAre long-term target effects, baseline and missing data known?Required |
Selected long-term whey-only baseline HbA1c/risk, ITT/PP, missing data/attrition, adjustment and sensitivity analyses are unverified. Short-term/combination iAUC values do not supply that target effect. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
ITT/PP, baseline/covariates, missing data/attrition, adjustment, repeats and sensitivity |
Material needed: Long-term baseline/models, ITT/PP, adjustment and missing-data/sensitivity analyses are unverified. This records needed materials; no new research was executed. |
| 27 |
Unverified |
Full text not readStored summary read |
N27 · Evidence conditionWhat are actual long-term whey exposure, discontinuation and adherence?Required |
Selected long-term whey-only actual intake, maintenance/discontinuation, adherence and links to outcome analysis are unverified. Short original exposure specifications are not long-term implementation data. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Product/dose, actual intake, discontinuation, tolerability, follow-up and exposure models |
Material needed: Long-term actual intake, discontinuation/maintenance and exposure/outcome links are unverified. This records needed materials; no new research was executed. |
| 28 |
Unverified |
Full text not readStored summary read |
N28 · Evidence conditionWhat intervals and plans exist for long-term HbA1c or complications?Required |
The original parent describes small-sample, surrogate, combination and hierarchy limitations. Long-term whey-only HbA1c/complication effects/CIs, power plans and clinical importance are unverified. Parent precision is unrecorded. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Direct effects/CIs, prespecified plans/power, importance and events/denominators |
Material needed: Long-term effects/intervals, prespecified plans/power and importance are unverified. This records needed materials; no new research was executed. |
| 29 |
Partly verified |
Full text not readStored summary read |
N29 · Evidence conditionHow are shared reports, populations and outcomes linked?Required |
Link Jakubowicz glucose/insulin/GLP-1, Smith short-term glucose metrics and Zameer combination iAUC by report. Related-report/cohort overlap and outcome-specific sample relationships are unverified. The guar mention is not added as a fictional report. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Report/registration/cohort, crossover periods, glucose/hormones and combination/whey-only relationships |
Material needed: Related reports/cohorts, unique-trial/participant counts and outcome-specific relationships are unverified. This records needed materials; no new research was executed. |
| 30 |
Partly verified |
Full text not readStored summary read |
N30 · Evidence conditionHow much direct replication of the same long-term whey-only question is preserved?Required |
The original counterview describes supporting postprandial direction in different short designs and consistent mechanisms. Direct replication material for selected long-term whey-only HbA1c/complications is unverified within preserved scope. This is not expanded into absence of all human research. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Whey formulation/alone, population, duration, comparator, HbA1c/complications and identity |
Material needed: Direct material for the same long-term whey-only question, conditions/identities and independence are unverified. This records needed materials; no new research was executed. |
| 31 |
Partly verified |
Full text not readStored summary read |
N31 · Evidence conditionAre NCT/ISRCTN identifiers separate from actual registration content?Required |
Original evidence registration values are NCT01571622, ISRCTN17563146 and NCT04905589. Actual registry content, dates, endpoints/analysis and amendments were not read in this work; only identifiers are preserved. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
NCT01571622, ISRCTN17563146, NCT04905589 and content/dates/hierarchy |
Material needed: Registry content/dates, timing relative to recruitment, endpoints/analysis and amendments are unverified. This records needed materials; no new research was executed. |
| 32 |
Partly verified |
Full text not readStored summary read |
N32 · Evidence conditionAt what level is industry/product involvement known?Required |
Original wording records health-ministry/Milk Council support for Jakubowicz, product/industry support and investigator involvement for Smith, and mixed academic/product-related support for Zameer. Detailed support/COI, design/analysis roles and independence are unverified. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Original ministry/Milk Council, Smith product/industry/investigator involvement and Zameer mixed support |
Material needed: Support/COI details, roles, analysis involvement and related-study independence are unverified. This records needed materials; no new research was executed. |
| 33 |
Partly verified |
Full text not readStored summary read |
N33 · Evidence conditionWhich material was actually read for this table?Required |
The complete stored parent summary is read for production and preserved unchanged. Bibliographic/report summaries are read as summaries; external abstracts, full texts, registration/plans and support material are unread, with no external access attempts. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Complete stored summary versus external abstracts, full texts, registration, plans and support |
Material needed: External material is unread; access failure or unavailability has not been established either. This records needed materials; no new research was executed. |
| 34 |
Partly verified |
Full text not readStored summary read |
N34 · Evidence conditionAre original evidence date, production and current review separate?Required |
Original evidence date is 2026-09-07, corrections are an empty list and deliberation an empty string. Historical parent cross-check wording does not establish completed review in this work. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Original date, empty corrections/deliberation and historical cross-check wording |
Material needed: Current content-review date and new clinical-verification date are unrecorded. This records needed materials; no new research was executed. |
| 35 |
Partly verified |
Full text not readStored summary read |
N35 · Evidence conditionAre selected long-term wording and original parent English preserved together?Required |
The selected English claim is Long-term whey-only HbA1c or complication benefit; its note says longer combinations cannot isolate whey. Original parent English key/summary wording separates acute whey, longer combinations and medication-replacement boundaries. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Long-term claim/notes in both languages versus acute/combination/long-term boundaries |
Material needed: Detailed original-paper, Korean/English translation and correction comparisons are unverified. This records needed materials; no new research was executed. |
| 36 |
Partly verified |
Full text not readStored summary read |
N36 · Evidence conditionHow are parent axes and absent subclaim values retained?Required |
Parent axes are B/S/R1/I0/E+/B2 with unrecorded precision. Original special-condition flags are false, derived grade is C and override reasons are empty. Separate selected-subclaim score, status and axes are absent. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Parent axes and unrecorded precision versus absent selected score/status/axes |
Material needed: Subclaim score/status/axes fields are absent; long-term precision is unverified. This records needed materials; no new research was executed. |
| 37 |
Partly verified |
Full text not readStored summary read |
N37 · Evidence conditionAre allergy/hypoglycemia cautions actual event data?Supplementary; required for extending long-term safety conclusions |
Original parent safety is Caution; its detail concerns milk-protein allergy and potentially hypoglycemia-causing medication. Actual allergy/hypoglycemia event counts and collection/assessment methods are unverified. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Harm definitions, original allergy/medication cautions, collection/assessment and event tables |
Material needed: Harm definitions/collection, assessors and actual event tables are unverified. This records needed materials; no new research was executed. |
| 38 |
Unverified |
Full text not readStored summary read |
N38 · Evidence conditionWhat are exposure, symptoms/discontinuation and long-term harm follow-up?Supplementary; required for extending long-term safety conclusions |
Original material concerns acute/7-day/combination glucose contexts. Actual harm onset/recovery, discontinuation and follow-up after long-term whey-only exposure are unverified. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Actual intake/meals, medication, event/recovery times and short-/long-term follow-up |
Material needed: Harm onset/recovery, discontinuation and long-term/post-intervention follow-up are unverified. This records needed materials; no new research was executed. |
| 39 |
Unverified |
Full text not readStored summary read |
N39 · Evidence conditionWhich comparator defines whey-only or combination harm comparisons?Supplementary; required for extending long-term safety conclusions |
Original control-drink, calorie-imbalance and combination conditions are recorded. Identical harm collection/windows across conditions, direct comparison tables and long-term whey-only control harms are unverified. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Arm-specific collection/timing, control drinks/calories, meals/medication and event tables |
Material needed: Harm comparators, identical collection/follow-up and original comparative outcomes are unverified. This records needed materials; no new research was executed. |
| 40 |
Unverified |
Full text not readStored summary read |
N40 · Evidence conditionAre harm counts and actual exposure/observation denominators available?Supplementary; required for extending long-term safety conclusions |
Original sample wording exists, but direct allergy/hypoglycemia harm counts, actual exposure/observation denominators, discontinuation and long-term follow-up are unverified. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Exposure/observation/arm denominators, harm counts, discontinuation and duration |
Material needed: Harm counts, actual exposure/observation denominators and duration are unverified. This records needed materials; no new research was executed. |
| 41 |
Partly verified |
Full text not readStored summary read |
N41 · Evidence conditionAre medication, meals, allergy and combination components distinguished?Supplementary; required for extending long-term safety conclusions |
Original safety wording mentions milk-protein allergy and potentially hypoglycemia-causing medication. Actual events, meals/medication/baseline risk, combination-component contributions and causal assessment are unverified. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Shared medication/meals, baseline risk, whey/guar/MCT and event chronology |
Material needed: Actual events, shared factors, baseline risks and causal assessments are unverified. This records needed materials; no new research was executed. |
| 42 |
Unverified |
Full text not readStored summary read |
N42 · Evidence conditionWhat are discontinuation/attrition and loss of harm reporting?Supplementary; required for extending long-term safety conclusions |
Arm-specific discontinuation/attrition, harm-data losses, selective reporting and long-term/later follow-up are unverified in the original summary. Not reading the original paper does not establish that the paper failed to report these items. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Discomfort/discontinuation reasons, arm-specific attrition, missing/selective harm reporting and later follow-up |
Material needed: Discontinuation/attrition, missing/selective harm reporting and later follow-up are unverified. This records needed materials; no new research was executed. |
| 43 |
Unverified |
Full text not readStored summary read |
N43 · Evidence conditionHow much is known about independent, vulnerable-population or long-term whey-only harms?Supplementary; required for extending long-term safety conclusions |
Short glucose/hormone and combination iAUC material within preserved scope is not direct verification of long-term whey-only safety. Independent harms, other treatment/disease populations and long-term/later follow-up are unverified. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Same-formulation/whey-only harms, independent reports, treatment/disease populations and follow-up |
Material needed: Independent harms, vulnerable/treatment populations and long-term whey-only follow-up are unverified. This records needed materials; no new research was executed. |
| 44 |
Partly verified |
Full text not readStored summary read |
N44 · Evidence conditionAre material versions, application and review status separate?Required |
Preserved methodological material, condition versions and production/application records are distinguished. Review of existing content and claim boundaries remains incomplete; this is not completed clinical review or official methodological certification. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Preserved methodological material, condition versions and production/application records |
Material needed: Completed content review or new official-method/external clinical certification is not established. This records needed materials; no new research was executed. |